JP2005515778A5 - - Google Patents

Download PDF

Info

Publication number
JP2005515778A5
JP2005515778A5 JP2003564211A JP2003564211A JP2005515778A5 JP 2005515778 A5 JP2005515778 A5 JP 2005515778A5 JP 2003564211 A JP2003564211 A JP 2003564211A JP 2003564211 A JP2003564211 A JP 2003564211A JP 2005515778 A5 JP2005515778 A5 JP 2005515778A5
Authority
JP
Japan
Prior art keywords
organism
tissue
nucleic acid
target nucleic
acid prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003564211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515778A (ja
JP4515767B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/002844 external-priority patent/WO2003064615A2/en
Publication of JP2005515778A publication Critical patent/JP2005515778A/ja
Publication of JP2005515778A5 publication Critical patent/JP2005515778A5/ja
Application granted granted Critical
Publication of JP4515767B2 publication Critical patent/JP4515767B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003564211A 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅 Expired - Fee Related JP4515767B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35359102P 2002-01-31 2002-01-31
PCT/US2003/002844 WO2003064615A2 (en) 2002-01-31 2003-01-31 Amplifying repetitive nucleic acid sequences

Publications (3)

Publication Number Publication Date
JP2005515778A JP2005515778A (ja) 2005-06-02
JP2005515778A5 true JP2005515778A5 (enExample) 2006-03-23
JP4515767B2 JP4515767B2 (ja) 2010-08-04

Family

ID=27663226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564211A Expired - Fee Related JP4515767B2 (ja) 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅

Country Status (9)

Country Link
US (2) US7695904B2 (enExample)
EP (1) EP1476561B1 (enExample)
JP (1) JP4515767B2 (enExample)
CN (1) CN100473723C (enExample)
AT (1) ATE534746T1 (enExample)
AU (1) AU2003208902B2 (enExample)
CA (1) CA2474468C (enExample)
ES (1) ES2379375T3 (enExample)
WO (1) WO2003064615A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5686493B2 (ja) 2003-01-24 2015-03-18 ユニバーシティ・オブ・ユタＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｕｔａｈ テロメアの長さを決定することによって死亡の危険性を予測する方法
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
WO2009029686A1 (en) 2007-08-27 2009-03-05 Longhorn Vaccines & Diagnostics Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
DK2195466T3 (da) 2007-10-01 2013-01-14 Longhorn Vaccines & Diagnostics Llc Fremgangsmåde til opbevaring af biologiske prøver
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CN101230403B (zh) * 2008-02-21 2010-12-29 浙江理工大学 解析染色体端粒g-末端序列的方法
WO2010045245A1 (en) 2008-10-17 2010-04-22 Geron Corporation Method for identification of sensitivity of a patient to telomerase inhibition therapy
CA2748265C (en) * 2008-12-22 2018-04-03 University Of Utah Research Foundation Monochrome multiplex quantitative pcr
US20110207128A1 (en) * 2010-02-16 2011-08-25 Cawthon Richard M Methods and kits for determining biological age and longevity based on gene expression profiles
JP2011223940A (ja) * 2010-04-21 2011-11-10 Asahi Breweries Ltd 偽陰性を排除するｐｃｒ検査方法およびそれに使用するプライマー
WO2012135125A1 (en) 2011-03-28 2012-10-04 Geron Corporation Telomere length measurement in formalin-fixed, paraffin embedded (ffpe) samples by quantitative pcr
WO2013054666A1 (ja) * 2011-10-13 2013-04-18 学校法人 東京女子医科大学 テロメア配列増幅用プライマー
WO2013101290A1 (en) * 2011-12-29 2013-07-04 Qiagen Methods of using telomeres as markers for aging
CN104203272A (zh) 2012-01-26 2014-12-10 长角牛疫苗和诊断有限责任公司 复合抗原序列及疫苗
US20130310269A1 (en) * 2012-05-04 2013-11-21 Austin So Hot-start digital pcr
CA2892445C (en) 2012-11-30 2022-06-28 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
US9200327B2 (en) 2012-11-30 2015-12-01 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
WO2014152937A1 (en) * 2013-03-14 2014-09-25 Ibis Biosciences, Inc. Nucleic acid control panels
WO2014152676A1 (en) * 2013-03-15 2014-09-25 New York University A method for a single cell analysis of telomer length
EP2971134B1 (en) * 2013-03-15 2023-10-25 Aegea Biotechnologies, Inc. Methods for amplifying fragmented target nucleic acids utilizing an assembler sequence
ES2762860T3 (es) * 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
GB201418144D0 (en) * 2014-10-14 2014-11-26 Univ Cardiff High throughput sequencing
CA2971169A1 (en) 2014-12-30 2016-07-07 Telomere Diagnostics, Inc. Multiplex quantitative pcr
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
US10577643B2 (en) * 2015-10-07 2020-03-03 Illumina, Inc. Off-target capture reduction in sequencing techniques
US10186789B1 (en) 2018-04-13 2019-01-22 Rustcraft Industries LLC Keyed cable and connector system
CN112029841B (zh) 2019-06-03 2024-02-09 香港中文大学 定量端粒长度和基因组基序的方法
US12485166B2 (en) 2020-02-06 2025-12-02 Longhorn Vaccines And Diagnostics, Llc Vaccines for the treatment and prevention of zoonotic infections
KR20230091978A (ko) 2020-10-20 2023-06-23 롱혼 백신즈 앤드 다이어그나스틱스, 엘엘씨 면역원성 항원
CN113862339B (zh) * 2021-12-01 2022-03-22 广州滴纳生物科技有限公司 核酸组合产品、检测试剂盒和扩增靶核酸的方法
CN116218893B (zh) * 2023-03-24 2025-07-29 哈尔滨医科大学 一种通过体外扩增重组质粒在其编码基因上生成短片段串联重复序列的方法
CN117230169B (zh) * 2023-11-13 2024-02-13 元码基因科技（北京）股份有限公司 用于长片段端粒序列测序的接头、预文库及其构建方法
CN117248003B (zh) * 2023-11-13 2024-04-12 元码基因科技（北京）股份有限公司 用于完整端粒扩增子测序的组合物、预文库及其构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020124A (en) * 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5512441A (en) * 1994-11-15 1996-04-30 American Health Foundation Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method
US5741677A (en) * 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
JP3718892B2 (ja) * 1996-02-05 2005-11-24 三菱化学株式会社 ヒト・テロメラーゼ活性の測定方法
JP4013333B2 (ja) 1998-06-05 2007-11-28 株式会社Ｂ＆Ｃラボラトリーズ 皮膚の老化度の測定方法および測定用キット
US6436677B1 (en) * 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription

Similar Documents

Publication Publication Date Title
JP2005515778A5 (enExample)
GB2423151B (en) Examination systems for biological samples
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
EP2560006A3 (en) Biomarkers for prostate cancer and methods using the same
JP2005523065A5 (enExample)
EP2177614A3 (en) Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
WO2005027733A3 (en) Biological markers for diagnosing multiple sclerosis
AU2003298245A1 (en) Method for analyzing the luminescence of chemical and/or biological samples
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
EP2186912A3 (en) Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
WO2006128042A3 (en) Methods of identifying mutations in nucleic acid
WO2002092858A3 (en) Methods of screening for disease
WO2005085860A3 (en) New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP1745778A3 (en) Diaminoalcohols as therapeutic compounds
EP1722230A3 (en) Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
WO2003091693A3 (en) Method for evaluating drug candidates
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
AU2003230865A8 (en) Observation of effects of body fluids on indicator cells for disease diagnosis
WO2007060671A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis